WIADOMOŚCI O NASZEJ GRUPIE
Stale pracujemy nad doskonaleniem naszych produktów, aby dostarczać pacjentom i zakładom opieki zdrowotnej bardziej zaawansowane wyroby mające na celu poprawienie i uproszczenie codziennej opieki zdrowotnej. Na tej stronie publikujemy wszystkie wiadomości i aktualizacje dotyczące naszej działalności.
Safe and effective use of a passive safety needle by healthcare professionals in a simulated environment, including perceptions and preferences
2023 – Needlestick injuries (NSIs) may potentially expose healthcare professionals (HCPs) to bloodborne pathogens. Safety needles are designed to protect against NSIs. We evaluated whether
MTD Group wins in the Top 5 of the „Best Innovative Device -Technology of the Year” category of the Life Science Excellence Awards (LSEA).
The MTD Group is proud to announce that its “G34 pen needle” device for insulin injection has received the highest award in the #LifeScienceExcellenceAwards 2022
MTD Group – a global leader in medical devices– today announced the FDA clearance obtained by its affiliate Pikdare S.p.A. for DropSafeTM SicuraTM passive safety
Lugano, 20th September 2022 – Medical Technology and Devices appointed Charles Bouaziz as new Chief Executive Officer of the Group. Charles is an industry veteran
MTD Exchange is a grassroots community program born with the objective to bring leaders, healthcare professionals and various stakeholders together to discuss and share experience
MTD Group takes part in the global effort to accelerate the COVID-19 vaccination, thanks to its new Low Dead Space syringes.
Lugano, 21st May 2021 – In delivering the COVID-19 global vaccination campaign, it is of paramount importance to be able to maximize the number of